chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I became very ill after the second dose of the vaccine.  I recovered a week later from the "sickness" portion of the after effects (coughing, body chills, sneezing etc).  Following the recovery, I began to notice an increase fatigue levels and mental confusion. Then came severe pins and needles sensations in my legs.  I noticed pain going down my leg and into my foot.  I have had EMGs, EKGs, EEMs, CT scans, X-rays, MRIs, a hip arthogram, multiple rounds of blood work, and an epidueral steriod injection into the spine for pain relief. I have been prescribed numerous drugs, including steriods.  None of this has helps.  I am rapidly losing weight and my joints feel like they have shards of glass in them.  My posture is
The patient received her HPV vaccine @1049 07/24/23. After a few minutes, the patient started to look mildly pale and started to feel dizzy. RN assisted the patient in lying down. The patient was alert and oriented, had no SOB, vitals stable, and was feeling better. The patient was wheeled to the car and discharged. The patient and mother were provided with information and signs and symptoms to bring to the emergency room.
Fever 99.3; pharyngitis productive cough, chest pain. Prescribed keflex 500 mg 3 times a day for 7 days.
Pt received 2nd dose of Moderna vaccine from a vial that had reached it's beyond use date 10 days prior.  Pt did not experience any adverse effects or side effects from this vaccine.
This case was reported by a pharmacist via call center representative and described the occurrence of acute disseminated encephalomyelitis in a 8-year-old male patient who received HAVRIX pediatric (batch number 4B299, expiry date 17th December 2016) and (batch number 4B299, expiry date unknown). Concomitant products included amoxicillin, azithromycin and ceftriaxone. On 23rd September 2014, the patient received HAVRIX pediatric. On an unknown date, the dose was an unknown dose. On 24th October 2014, 31 days after receiving HAVRIX pediatric, the patient experienced headache and fever. On 3rd November 2014, the patient experienced acute disseminated encephalomyelitis (serious criteria hospitalization, disability, GSK medically significant and clinically significant/intervention required), leg pain (serious criteria hospitalization and disability), numbness (serious criteria hospitalization, disability and clinically significant/intervention required), urinary retention (serious criteria hospitalization, disability, GSK medically significant and clinically significant/intervention required), muscle disorder (serious criteria hospitalization, disability and clinically significant/intervention required), bladder incontinence (serious criteria hospitalization, disability and clinically significant/intervention required) and tingling (serious criteria hospitalization, disability and clinically significant/intervention required). On an unknown date, the outcome of the acute disseminated encephalomyelitis, leg pain, numbness, muscle disorder, fever and tingling were recovering/resolving and the outcome of the headache was recovered/resolved and the outcome of the urinary retention and bladder incontinence were unknown. The reporter considered the acute disseminated encephalomyelitis, headache, leg pain, numbness, urinary retention, muscle disorder, fever, bladder incontinence and tingling to be possibly related to HAVRIX pediatric. Additional details provided: Pharmacist reports a patient who started experiencing a fever and headache about 1 month after receiving a HAVRIX vaccine. He went to the ER and it was thought that he had sinusitis and was given oral antibiotics. The headache and fever continued and he was admitted to the hospital on 11/3/2014 with leg pain, numbness and tingling and bladder incontinence. The patient was diagnosed with acute disseminated encephalomyelitis (ADEM) and started on steroid therapy. The patient was still complaining of poor muscle control and tingling. He has a Foley in place so the pharmacist was unable to evaluate how the bladder was progressing. She considered some of these symptoms to be disabling because he was not able to move around and be mobile because of the poor muscle control, tingling and poor bladder control. She considered the patient jeopardized because there were concerns that the tingling and poor muscle control, as well as the MRI abnormalities meant he might no longer be able to walk, so he was started on steroid therapy as an intervention.
Nausea; fever; chills; headache; tired; diarrhea which led to loss of fluids; low blood pressure; This is a spontaneous report received from a contactable consumer. A 65-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 18Mar2021 09:30 am (Batch/Lot Number: En6204) as single dose for covid-19 immunisation. Medical history included high blood pressure. The patient's concomitant medications within 2 weeks of vaccination were not unspecified. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient previously received cefaclor (CECLOR) and experience allergies, and also received first dose of BNT162B2 (Lot number= En6200) on 25Feb2021 09:30 AM at single dose at left arm for COVID-19 immunization. The patient experienced nausea, fever, chills, headache, tired and diarrhea which led to loss of fluids and low blood pressure in Mar2021 08:00 PM with outcome of recovering. The adverse events resulted in hospitalization, life threatening illness (immediate risk of death from the event), disability or permanent damage, emergency room/department or urgent care. Patient received treatments for the events included fluids, medicine, partial colon removal. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient had been tested for COVID-19: negative in Mar2021. Additional information has been requested.
COVID; COVID; The initial case was missing the following minimum criteria: Unspecified product. Upon receipt of follow-up information on 27Feb2023, this case now contains all required information to be considered valid.  This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 93-year-old male patient received BNT162b2 (BNT162B2), on 27Jan2021 as dose 1, single (Batch/Lot number: unknown) and on 12Feb2021 as dose 2, single (Batch/Lot number: unknown) at the age of 92 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant) all with onset 04Sep2021, outcome "unknown" and all described as "COVID". The patient was hospitalized for drug ineffective, covid-19 (start date: 08Sep2021). Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Probable started about 04Sep2021, was given 2 shots. 9-4-didnt knew at that time. On way to High school reunion, felt a little odd then, stopped, no conclusion sought felt ok at reunion. Patient was back on the same day, felt very unpleasant. Saturday, went to (withheld). Monday, woke up, was 08Sep2021, patient knew he was sick. Called physician, about 20 minutes, told patient he had the COVID and was admitted.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a nurse practitioner concerning a 19-20 year old female who was vaccinated with the first dose of GARDASIL, and then after receiving the vaccine, the patient had fell off the exam table and hit her head on the counter. The nurse practitioner reported that the patient recovered, and then two months later had received the second dose of the vaccine. Unspecified medical attention was sought. No further AE information provided. Additional information has been requested.
The shot was administered in the afternoon on 3/3/15. Two days later his mother called, stating that patient's arm became very red and swollen. In the clinic (same day) the PA observed that the redness measured approx. 12 cm x 12 cm. The child only c/o pain upon applying pressure to the rash. The child came back to the clinic 6 days later (3/11/15). Patient's rash circumference decreased, however the color was a darker purple, swelling with firmness noted. No fever at any time. 3/4/15-the patient was given ibuprofen and a cold compress applied to his arm. That is the extent of his treatment.
Patient came in complaining of rash on right side of trunk above abdomen and on back in a big patch. Very itchy. Denied lawn work (asked to rule out poison ivy/oak/sumac).
Starting early January of 2022, I developed 2 days of explosive vomiting resolved by fluid and bed rest. Next episode, 02/13/2022 2 days of explosive vomiting resolved by drinking fluids, bed rest and the "BRAT" diet. 03/09/2022: I was seen for high calcium in blood and urine labs, and high blood pressure. Resolution still pending as I am undergoing more tests. 04/12/2022: seen for cataract evaluation, unresolved and more exams pending. 05/02/2022: Seen by endocrinology again for high blood pressure and calcium in urine, more tests pending. 05/04/2022: prescribed amlodipine for high blood pressure. 05/16/2022: underwent tests for high calcium levels and possibly due to a thyroid condition.
Headache/Fatigue set in about 1 hour after my second does of the Pfizer vaccine.  It only lasted for about an hour.  Rest helped alleviate the symptoms.
Diminished, change, Loss of taste and smell; Diminished, change, Loss of taste and smell; Diminished, change, Loss of taste and smell; Diminished, change, Loss of taste and smell; Diminished, change, Loss of taste and smell; Diminished, change, Loss of taste and smell; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 16Aug2021 as dose 2, single (Lot number: FA6780) at the age of 50 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Previous dose details:, Prev dose product=COVID 19,, Prev dose brand=Pfizer , Prev dose brand unknown=False,, Prev dose lot number=FA6780, Prev dose lot unknown=False, Prev dose Administration date=26Jul2021, Prev dose dose number=1), administration date: 26Jul2021, when the patient was 50-year-old, for Covid-19 immunization. The following information was reported: ANOSMIA (non-serious), HYPOSMIA (non-serious), TASTE DISORDER (non-serious), HYPOGEUSIA (non-serious), AGEUSIA (non-serious), PAROSMIA (non-serious) all with onset 01Sep2021, outcome "not recovered" and all described as "Diminished, change, Loss of taste and smell". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of anosmia, hyposmia, taste disorder, hypogeusia, ageusia, parosmia.  Additional information: Prior to vaccination, Patient has no covid
Patient admitted to medical facility for fall with subdural hematoma and subarachnoid hemorrhage. COVID test on admission was positive (on 12/22/21)
Information has been received from a company representative via a nurse concerning a 16 year old female who on 18-JAN-2008 was vaccinated with a first dose of GARDASIL (lot# unknown) injection in the deltoid area. On 18-JAN-2008 the patient fainted after receiving her dose of GARDASIL. Medical attention was sought. Subsequently, the patient recovered from fainting approximately 20 minutes. No further information was available. Additional information has been requested. This is one of two reports.
Patient contacted me on 2/16/22 at 11:35am to state that she began side effects on 2/12/22 but they are persisting.  Nausea occurred but is now resolved. Patient has had red blotchy patches below the vaccination site that extend down to the elbow.  They began to itch on 2/16/22.  The left armpit lymph node is sore and feels pinched when she moves arm.  Her lymph nodes/glands bilateral jaw are sore.  She continues to sweat and have hot flashes.  I
Next day morning I felt the dose is heavy, due to which inflammation inside the body. Got red coloured rashes and rashes area is swollen. Initial few days these rashes were 10-15 in numbers and small in size (5mm-20mm) all orotund the body. I am facing the same issues since then but recently there are more development in these rashes - these rashes got WORST, it?s all over my body and got bigger in size ( one finger size to one palm size). I am stressed as these got bigger and it?s winter season so feels like scratch if skin is dry. I am planning to visit doctor.
She reports experiencing strong neck pain and stiffness yesterday and then felt the pain move up covering her head. States she cannot raise her arm. Patient states she is also experiencing nausea and stomach pain. States her cheeks feel very hot and she feels pressure in her eyes.
Patient received the vaccine in error at age 13 when the EUA authorizes vaccine for ages 16 and older.
lt side of shoulder,neck, back, sore sl-3rd day post vax face swollen-pt taking APAP;could not open mouth on lt side;swollen lump on inside felt jerky, vision blurry, crying d/t pain;
Extreme fatigue continuing for 2 months until acpuncture treatments. Painful muscle aches all over body beginning about a week after fatigue dissipated.
she doesn't feel good; can't catch her breath; rib cage is kind of sore; Chills; This is a spontaneous report from a contactable consumer (patient). A 81-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on 23Feb2021 as 2nd dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On 23Feb2021 (last night), patient experienced chills. At 21:30, rib cage was kind of sore. On 24Feb2021 at 21:00, patient can't catch her breath. It was reported that chills stopped last night. Outcome: attempted to capture outcome of chills, unable to confirm if recovered completely or with last effects. The patient stated that they stopped last night, she does not have chills now but she does not feel good. Patient was calling to see what should she do. Should the patient go to a walk in. It was reported that patient handed phone to (name), because she said she had to catch her breath, to provide mailing address who also provided details intermittently during report. However, patient provided most of details during interaction. The patient was calling because she wanted us to advise her on what to do to get relief. She went online for urgent care and could not be seen until 11:00. She was hoping we would be able to get her in at Banner. She mentioned she waited almost an hour to wait to talk. The outcome of the event can't catch her breath was not recovered and outcome of the event chills was recovered and outcome of the others events was unknown.   Information on the lot/batch number has been requested.  Follow-up (14May2021): Follow-up attempts completed. No further information expected
patient become light headed, difficulty breathing/SOB,  dizziness, felt faint, appeared to be choking, arms numb  epi pen administered Moderna Covid-19  vaccine EUA
At the injection site, my arm turned red and swelled. This lasted 3 days and then went away. After receiving the vaccine, I had some redness that went away after a week. It came back 3 days later. I went to the doctor because its recurrence concerned me. My doctor advised not to worry because it could just be a delayed side effect.
still feel fatigued; nausea; soreness in my left arm (injection site) as well - and oddly my right arm too - especially day 2 post; was accompanied by excruciating chest pains and the body pains were unbearable.; vomited for a couple hours with chills and sweats; vomited for a couple hours with chills and sweats; vomited for a couple hours with chills and sweats; Awful body aches and a massive headache followed.; Awful body aches and a massive headache followed...; experienced soreness in my left arm (injection site) as well - and oddly my right arm too - especially day 2 post; gestational_period: 22; This is a spontaneous report from a contactable consumer (patient). A 36-years-old female pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 22Apr2021 at 12:30 hours (Batch/Lot Number: EW0172) as DOSE 2, SINGLE (at the age of 36-years-old) for COVID-19 immunisation. The patient's medical history was not reported. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 01Apr2021 at 12:30 PM (Batch/Lot Number: EW0150) as DOSE 1, SINGLE (at the age of 36-years-old) for COVID-19 immunisation. Concomitant medications included prenatal vitamins and vitamin D. The night of the vaccine, on 23Apr2021, the patient woke up around 1:00 AM & vomited for a couple hours with chills and sweats. Awful body aches and a massive headache followed. Only somewhat comfort the patient could find was with a cold compress on her forehead and running baths for the body aches. The patient then started feeling a bit better, had a nap and woke up to more vomiting early evening (about 29 hours after vaccine) but was accompanied by excruciating chest pains and the body pains were unbearable. The patient almost went to the hospital but called a family friend/nurse and decided to wait it out a bit and it eventually passed. The next day, the patient woke up with an appetite/feeling better but then the body aches and nausea (not vomiting) returned that afternoon/spent the rest of that day in bed. On26Apr2021, 4 days post vaccine injection, the patient still feel fatigued and a bit achy. The patient also reported definitely experienced soreness in my left arm (injection site) as well - and oddly my right arm too - especially day 2 post (on 24Apr2021). The patient reported she was pregnant while taking bnt162b2. The patient's last menstrual date was 18Nov2020. The patient was 22 Weeks pregnant at the onset of the event. The patient was due to deliver on 24Aug2021. The patient received no treatment for the adverse events. The patient did not have COVID prior to vaccination and had not COVID tested post vaccination. The patient did not have other vaccine in four weeks. The patient recovered from the events on an unspecified date in 2021. The clinical outcome for the event gestational_period: 22 was unknown.
4 pm freezing (fever) then hot, upset stomach, headache. Went to ER 2AM. Fever 104.6. Stayed overnight, released next day.
inadvertently administering 1st dose of Moderna, COVID-19 vaccine to a 17 years old patient; A spontaneous report was received from a nurse, concerning a 17 year old, patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and inadvertently administering first dose of Moderna, Covid-19 vaccine to a 17 yeaer old patient.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 20 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot #025L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 20 Jan 2021, the reporter reported that they inadvertently administered first dose of Moderna, Covid-19 vaccine to a 17 year old patient. No adverse events were reported.   Action taken with mRNA-1273 in response to the event was not reported.  The event was considered resolved on 20 Jan 2021.; Reporter's Comments: This case concerns a 17 year old patient received their first of two planned doses of mRNA-1273 (Lot #025L20A) intramuscularly for prophylaxis of COVID-19 infection. There we no reported adverse events after the vaccine was administered in the case of  product administered to patient of inappropriate age.
dizziness, lightheadedness within a few minutes of receiving influenza vaccine. Pt. was instructed to stay until symptoms subsided. Given water and something to eat.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug, allergy history or concomitant medications. On 30-AUG-2017, the patient was vaccinated with an improperly stored dose of ZOSTAVAX (strength, frequency, lot# and expiration date were not provided) for prophylaxis. The doses of ZOSTAVAX were exposed to a temperature excursion of 6° Fahrenheit (°F) to 14°F (7.9°F) during a time frame of 3 hours and 45 minutes, which was not detected by the data logger. There was no previous temperature excursion. No adverse effects were reported.
Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022; No adverse event; Dose administered after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date), PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022) and NO ADVERSE EVENT (No adverse event) in a 64-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch nos. 003K21-2A, 022C21A, 053C21A and 013H21B) for COVID-19 prophylaxis.     The patient was never diagnosed with or tested positive for COVID-19.  Concurrent medical conditions included Blood pressure high. Concomitant products included AMLODIPINE BESILATE (NORVASC) for an unknown indication.   On 20-May-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) .5 milliliter. On 17-Jun-2021, received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to .5 milliliter. On 18-Jan-2022, received third dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to .25 milliliter. On 26-May-2022 at 10:26 AM, received fourth dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to .25 milliliter. On 26-May-2022 at 10:26 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date), PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related and EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date) to have an unknown relationship. No further causality assessment was provided for PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022).    The vial did not undergo any temperature excursions. The vial was initially stored in the refrigerator on 21-Jan-2022. Number of vials involved was 5. The used vials were placed in the refrigerator on the same day of administration on 26 May 2022. The event did not cause the patient to seek medical care. It was unknown whether there are any other potential causes for the event to occur and patient experienced any similar event in the past.   No treatment medication reported by reporter.
pt reported a swallowing arm at the site of injection, recommended to use Benadryl
mom states about 48hr p/vax pt would not sleep, eyes rolled back;started to shake;high pitched cry;had 1 shaky spell about 4oclock;had another one about 1hr later;took to ER;adm x 2 day;